Evaluation of mechanisms for trans-nationalizing research and development for reducing life cycle
Abstract
The article demonstrates that alongside the process of trans-nationalizing the scientific driven and hightech production there is a trend arising in trans-nationalising scientific-technological sphere and global venture capital. There is evaluated the scale of the diffusion of Russian venture capital and its investment preferences. Using the examples of projects, related to the development of the new generation of antitumor drugs, there are analysed models for reducing the life cycle of domestic scientific developments in the format of using the benefits of various national innovation ecosystems and practices. A conclusion is made about the relevancy of reproduction of the life cycle of a high-tech product in the global scope of resources, markets and investments.
About the Author
F. A. Kurakov
The Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia
Russian Federation
Russian Federation
References
1. Vafina N. Kh. (2002) Transnational productions in the light of the theory of self-organisation of economic systems. Мoscow.: Izdatelstvo KFGI. 316 p.
2. Frumkin К. (2016) Participate in the revolution. Russian oligarchs are looking for foreign startups / Company, 18.04.2016. http://ko.ru/glavnoe/item/132235- uchastvovat-v-revolyutsi.
3. Kuznetsova T., Ovchinnikova О. (2007) Andrey Gudkov: We have been sitting on the substitutes bench for too long / Novaya gazeta, 26.11.2007. http://old.novayagazeta.ru/data/2007/kentavr07/00.html.
4. Molecular biologist Andrey Gudkov: Cancer and an old age – brothers-twins (2016) / Econet,29.05.2016. http://econet.ru/articles/117789-molekulyarnyy-biolog-andrey- gudkov-rak-i-starostbratya-bliznetsy.
5. ROSNANO and Cleveland BioLabs create an enterprise for developing innovative and anti-cancer and anti-infection medication (2011) / Rosnano, 26.09.2009. http://www.rusnano.com/about/presscentre/news/75694.
6. Product portfolio (2016) / Cleveland BioLabs. http://www.cbiolabs.com.
7. Cleveland BioLabs Inc – Form 8-K. Filed 11/05/14 for the Period Ending 11/05/14 (2014) / http://www.barchart.com/plmodules/?module=secFilings&filingid=10282454&type=CONVPDF&popup=1&override=1&symbol=CBLI.
8. Ivanov А. (2014) Panacela Labs will receive 146 million Rubles for research of the new range of medication / TASS, 28.11.2014. http://tass.ru/nanotehnologii/1609074.
9. Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M–VM3) and Placebo in Patients With Prostate Cancer (2015) / ClinicalTrials. https://clinicaltrials.gov/ct2/show/NCT02654938.
10. OOO Inkuron (2016) / Inkuron. http://incuron.ru/ru/? s5_responsive_switch_incuronru=0.
11. Tartis-Starenie (2016) / Portal Skolkovo. https://sk.ru/net/1110133.
Review
For citations:
Kurakov F.A. Evaluation of mechanisms for trans-nationalizing research and development for reducing life cycle. Economics of Science. 2016;2(3):224-230. (In Russ.)
Views:
700
Email this article 